Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Endocrine|December 19, 2022
Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational studyChandani Patel Patel Chavez, Eddison Godinez Leiva, Diliara Bagautdinova, et al.
The American Journal of Managed Care|June 15, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersKeith C Bible, Robert C Smallridge, John C Morris, et al.
Journal of Oncology Practice|September 4, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancersKeith C Bible, Robert C Smallridge, John C Morris, et al.
Thyroid : Official Journal of the American Thyroid Association|June 16, 2020
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerKeith C Bible, Michael E Menefee, Chia-Chi Josh Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Management of Immunotherapy-Related Toxicities, Version 1.2019John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2020
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in OncologyJohn A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Plos Genetics|February 20, 2014
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaMitesh J Borad, Mia D Champion, Jan B Egan, et al.
Pageof 10